Search Results - "Turlán, V Compaired"

CP-195 Evolution of immuno-oncology clinical trials in a tertiary university hospital by Tena, I Puértolas, López, MA Alcácera, Jario, MPPardo, Sánchez, MJCumbraos, Calvo, S Gamarra, Oreja, O Horna, Turlán, V Compaired, Bañuelos, B Abad

“…BackgroundCurrently, immunotherapy is a very active area of oncology research. It is a treatment that uses the body’s own natural defences to kill cancer…”
Get full text

PS-069 Evaluation of post-chemotherapy toxicities in cancer patients who attended the emergency service by Alonso, E Fernández, Cáceres, A Rodrigo, Pérez, A Callejo, López, MA Alcácera, Samanes, MA Sagredo, Insa, S Trueba, Andreu, M Merchante, Tena, I Puértolas, Gracia, M Gimeno, Turlán, V Compaired

“…BackgroundCancer patients are characterised by a high frequency of attendance at the emergency services. Specialised care is required due to complications from…”
Get full text

Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population by Gimeno-Gracia, Mercedes, Crusells-Canales, María José, Armesto-Gómez, Francisco Javier, Compaired-Turlán, Vicente, Rabanaque-Hernández, María José

“…The percentage of older HIV-positive patients is growing, with an increase in age-related comorbidities and concomitant medication. To quantify polypharmacy…”
Get full text

CP-127 Switching from intravenous to subcutaneous formulation of TRASTUZUMAB: costs and safety by López, MA Alcácera, Samanes, MA Sagredo, Tena, I Puertolas, Alonso, E Fernández, Turlan, V Compaired, Sanchez, MJ Cumbraos, Pérez-Surio, A Frutos, Serrano, B Bonaga

“…BackgroundTrastuzumab containing regimens are the standard of care for HER2+ breast cancer. While intravenous trastuzumab (Tiv) is administered as a weight…”
Get full text